Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent β-cells in diabetic rats: In vivo and in vitro studies

Journal of Endocrinology

Volumn 155, Issue 2, 1997, Pages 369-376

  Dachicourt, N ^a   Serradas, P ^a   Bailbe D ^a   Kergoat, M ^b   Doare L ^b   Portha, B ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Chilly Mazarin Research Center   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCOSE; INSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; CULTURE TECHNIQUES; CYCLIC AMP; DIABETES MELLITUS, EXPERIMENTAL; DNA; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; ISLETS OF LANGERHANS; MALE; NEUROTRANSMITTER AGENTS; PEPTIDE FRAGMENTS; PERFUSION; RATS; RATS, WISTAR;

EID: 0030680180     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1550369     Document Type: Article

References (29)

1. Ahrén B 1994 Antidiabetogenic action of truncated glucagon-like peptide-1 in mice. Endocrine 3 367-369.
2. Ahrén B 1996 Glucagon-like peptide-1 (7-36)amide increases cyclic AMP accumulation in normal islets. Pancreas 12 211-213.
3. Bell GI, Santerre RF & Mullenbach GT 1983 Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 302 716-718.
4. Dachicourt N, Serradas P, Giroix MH, Gangnerau MN & Portha B 1996 Decreased glucose-induced cAMP and insulin release in islets of diabetic rats. Reversal by IBMX, glucagon, GIP. American Journal of Physiology (Endocrinology and Metabolism) 34 E725-E732.
5. Drucker DJ, Philippe J, Mojsov S, Chick WL & Habener JF 1987 Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proceeding of the National Academy of Sciences of the USA 84 3434-3438.
6. Eizink DL, Sandler S, Welsh N & Hellerström G 1988 Preferential reduction of insulin production in mouse pancreatic islet maintained in culture after streptozotocin exposure. Endocrinology 122 1242-1249.
7. Fehnunn HC & Habener JF 1992 Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma βTC-1 cells. Endocrinology 130 154-166.
8. Freychet P, Roth J & Neville DM 1971 Monoiodo-insulin: demonstration of biological activity and binding to fat cells and liver membranes. Biochemical and Biophysical Research Communications 43 400-405.
9. Giroix MH, Vesco L & Portha B 1993 Functional and metabolic perturbations in isolated pancreatic islets trom the GK rat, a genetic model of non insulin-dependent diabetes. Endocrinology 132 1-8.
10. G̈oke R & Conlon JM 1988 Receptors for glucagon-like peptide-1(7-36)-amide on rat insulinoma derived cells. Journal of Endocrinology 116 357-362.
11. Göke R, Fehmann HC & Göke B 1991 Glucagon-like peptide-1 (7-36) amide is a new incretin/enterogastrone candidate. European Journal of Clinical Investigation 21 135-144.
12. Grill V, Westberg M & Östenson GC 1987 β-cell insensitivity in a rat model of non-insulin-dependent diabetes. Evidence for a rapid reversible effect of previous hyperglycemia. Journal of Clinical Investigation 80 664-669.
13. Holz GG, Kühtreiber WM & Habener JF 1993 Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 361 362-365.
14. Inoué K, Cetkovic-Cvrlje M, Eizink DL & Grill V 1994 Irreversible loss of normal beta-cell regulation by glucose in neonatally streptozotocin diabetic rats. Diabetologia 37 351-357.
15. Lacy PE & Kostianovsky M 1967 Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16 35-39.
16. Malaisse-Lagae F & Malaisse WJ 1984 Insulin release by pancreatic islets. In Methods in Diabetes Research, vol 1, pp 147-152. Eds J Larner and L Pohl. New York: J Wiley and Sons.
17. Mizumo A & Shimma K 1996 Extrapancreatic action of truncated GLP-1 in NIDDM model rats, OLETF. Program of 56th Annual Meeting and Scientific Sessions, Moscone Center, San Francisco, California, p153A (abstract).
18. Mojsov S, Heinrich G, Wilson B, Ravazzola M, Orci L & Habener JF 1986 Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. Journal of Biological Chemistry 261 1880-1889.
19. Mojsov S, Weir GC & Habener JF 1987 Insulinotropin: glucaon-like peptide-(17-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. Journal of Clinical Investigation 76 616-619.
20. Otonkoski T & Hayek A 1995 Constitution of a biphasic insulin response to glucose in human fetal pancreatic β-cells with glucagon-like peptide-1. Journal of Clinical Endocrinology and Metabolism 80 3779-3783.
21. Portha B, Levacher C, Picon L & Rosselin G 1974 Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes 23 889-895.
22. Portha B, Giroix MH, Serradas P, Welsh N, Hellerström C, Sener A &: Malaisse WJ 1988 Insulin production and glucose metabolism in isolated pancreatic islets of rats with NIDDM. Diabetes 37 1226-1233.
23. Schmidt WE, Siegel EG & Creutzfeldt W 1985 Glucagon-like peptide-1 but not glucagon-peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 28 704-707.
24. Thorens B &: Waeber G 1993 Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDUM. Diabetes 42 1219-1225.
25. Tominaga M, Ikezawa Y, Yamatani K, Manaka H, Eguchi H, Oaimon M & Sasaki H 1996 Effect of glucagon-like peptide-1(7-37) on in vivo insulin sensitivity of rats. Program of 56th Annual Meeting and Scientific Sessions, Moscone Center, San Francisco, California, p153A (abstract).
26. Van Dijk G, Lindskod S, Holst JJ, Steffens AB & Ahrén B 1996 Effects of glucagon-like peptide-I on glucose turnover in rats. American Journal of Physiology 27 E1015-E1021.
27. Villanueva-Penacarrillo ML, Alcantara AI, Clemente F, Delgado E & Valverde I 1994 Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle. Diabetologia 37 1163-1166.
28. Weir GC, Leahy JL & Bonner-Weir S 1986 Experimental reduction of β-cell mass: implications for the pathogenesis of diabetes. Diabetes/Metabolism Reviews 2 125-161.
29. Widmann C, Burki E, Dolci W & Thorens B 1994 Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by endogenous receptors of beta cell lines. Molecular Pharmacology 45 1029-1035.